(2) Record, as and when reasonably possible, and retain for as long as the covered model is made available for commercial, public, or foreseeably public use plus five years information on the specific tests and test results used in the assessment pursuant to paragraph (1) that provides sufficient detail for third parties to replicate the testing procedure.
(3) Take reasonable care to implement appropriate safeguards to prevent the covered model and covered model derivatives from causing or materially enabling a critical harm.
(4) Take reasonable care to ensure, to the extent reasonably possible, that the covered model’s actions and the actions of covered model derivatives, as well as critical harms resulting from their actions, can be accurately and reliably attributed to them.